Wertpapierdatensatz · archiviertes Quartal
SPRY
ARS Pharmaceuticals, Inc. · Healthcare · Biotechnology
13Erfasste Halter
-4Δ Inhaber
17.49MGehaltene Aktien
$175.83MGemeldeter Wert
+1Neue Positionen
−5Ausstiege
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -23.5% ·
Aktienfluss -18.0% ·
neue Nettopositionen -20.0%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
Beteiligung im Zeitverlauf
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 74 | +1 | 32.54M | $260.86M | +8 | −7 |
| Q1 2026 | 76 | +2 | 39.92M | $320.66M | +9 | −7 |
| Q4 2025 | 74 | +1 | 37.60M | $438.08M | +2 | −1 |
| Q3 2025 | 13 | -4 | 17.49M | $175.83M | +1 | −5 |
| Q2 2025 | 14 | 0 | 19.24M | $335.74M | +1 | −1 |
| Q1 2025 | 11 | +2 | 5.28M | $66.41M | +2 | — |
| Q4 2024 | 9 | -2 | 6.14M | $64.82M | — | −2 |
| Q3 2024 | 10 | +2 | 3.52M | $51.10M | +3 | −1 |
| Q2 2024 | 8 | — | 1.67M | $14.24M | — | — |
Wer es hält · Q3 2025
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passiv) | 4.83M | +9.2% | $48.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passiv) | 4.83M | +9.2% | $48.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passiv) | 4.83M | +9.2% | $48.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passiv) | 4.83M | +9.2% | $48.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passiv) | 4.83M | +9.2% | $48.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 4.83M | +9.2% | $48.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 4.83M | +9.2% | $48.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 4.83M | +9.2% | $48.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 4.83M | +9.2% | $48.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 4.83M | +9.2% | $48.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passiv) | 4.83M | +9.2% | $48.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passiv) | 3.50M | +7.3% | $35.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passiv) | 3.50M | +7.3% | $35.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passiv) | 3.50M | +7.3% | $35.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passiv) | 3.50M | +7.3% | $35.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passiv) | 3.50M | +7.3% | $35.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (passiv) | 2.90M | +31.9% | $29.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 1.59M | -29.3% | $15.94M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 1.59M | -29.3% | $15.94M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passiv) | 1.51M | +12.2% | $15.13M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | Geode Capital Management ✦ (passiv) | 1.51M | +12.2% | $15.13M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Goldman Sachs Group ✦ | 1.33M | — | $13.32M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Goldman Sachs Group ✦ | 1.33M | — | $13.32M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Fidelity (FMR) ✦ | 742.51K | -52.6% | $7.46M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | Fidelity (FMR) ✦ | 742.51K | -52.6% | $7.46M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 700.41K | — | $7.04M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 700.41K | — | $7.04M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 700.41K | — | $7.04M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 700.41K | — | $7.04M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 700.41K | — | $7.04M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 700.41K | — | $7.04M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Marshall Wace ✦ | 197.32K | +394.4% | $1.98M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Marshall Wace ✦ | 197.32K | +394.4% | $1.98M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Marshall Wace ✦ | 197.32K | +394.4% | $1.98M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | Two Sigma Investments ✦ | 72.18K | Neu | $725,379 | 0.0% | New | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 70.12K | — | $704,686 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 70.12K | — | $704,686 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 70.12K | — | $704,686 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 70.12K | — | $704,686 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 70.12K | — | $704,686 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 70.12K | — | $704,686 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 70.12K | — | $704,686 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 70.12K | — | $704,686 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | D. E. Shaw & Co. ✦ | 34.22K | -40.4% | $343,901 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 45 | D. E. Shaw & Co. ✦ | 34.22K | -40.4% | $343,901 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 46 | T. Rowe Price ✦ | 33.79K | +23.4% | $340,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Two Sigma Investments | $725,379 | 0.0% |
Ausgestiegen
| Adage Capital Partners | $30.15M | war 0.1% |
| Wellington Management | $25.01M | war 0.0% |
| Millennium Management | $15.32M | war 0.0% |
| Gotham Asset Management | $475,617 | war 0.0% |
| AQR Capital Management | $281,503 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 201 Inhaber, 92.94M Anteile, $730.00M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Häufig gemeinsam gehalten
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Herkunft: Beteiligung aus geparsten 13F-Common-Stock-Positionen (verfolgte Grundgesamtheit, vergleichbare Sets für Veränderungen); Insider-Zeilen aus Formularen 3/4/5; Beteiligungen aus Schedules 13D/13G; jede Einreichung verlinkt auf das Original auf SEC EDGAR.
Berichtszeitraum: Q3 2025 ·
Methodik ·
Über die API abrufen